You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 56 Issue 4

October 2003

Volume 56, Issue 4

Pages 347–474

  1. Editor's View

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Features of this month's Journal (pages 347–348)

      J. K. Aronson

      Version of Record online: 18 JUN 2003 | DOI: 10.1046/j.1365-2125.2003.01898.x

  2. Editorial

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      The BPS web site for Continuing Professional Development in Clinical Pharmacology and Therapeutics (pages 349–350)

      John Mucklow, Nigel Baber, Simon Maxwell and Munir Pirmohamed

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01971.x

  3. Reviews

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Evaluation of new therapies for inflammatory bowel disease (pages 351–361)

      E. Carty and D. S. Rampton

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01965.x

      • image
    2. You have free access to this content
      Evaluation of drug treatment in irritable bowel syndrome (pages 362–369)

      Nicholas J. Talley

      Version of Record online: 29 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01966.x

  4. Pharmacokinetics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Population pharmacokinetics of liposomal daunorubicin in children (pages 370–377)

      Georg Hempel, Dirk Reinhardt, Ursula Creutzig and Joachim Boos

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01886.x

      • image
      • image
      • image
      • image
      • image
  5. Pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans? (pages 378–387)

      S. Freudenthaler, P. Benöhr, A. Grenz, T. Selzer, T. Schmidt, K. Mörike, H. Osswald and C. H. Gleiter

      Version of Record online: 20 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01894.x

      • image
      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin (pages 388–394)

      Ashok Purohit, Michel Melac, Gabrielle Pauli and Nelly Frossard

      Version of Record online: 20 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01897.x

      • image
      • image
      • image
      • image
  6. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects (pages 395–406)

      Wei-chi Liao, Ole Vesterqvist, Carol Delaney, Mohammed Jemal, Irene Ferreira, Neville Ford, Brian Swanson and Howard Uderman

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01888.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction (pages 407–414)

      René Bruno, Pascale Baille, Sylvie Retout, Nicole Vivier, Christine Veyrat-Follet, Ger-Jan Sanderink, Richard Becker and Elliott M. Antman

      Version of Record online: 20 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01904.x

      • image
      • image
      • image
  7. Pharmacogenetics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes (pages 415–421)

      Karin Herrlin, Norio Yasui-Furukori, Gunnel Tybring, Jolanta Widén, Lars L. Gustafsson and Leif Bertilsson

      Version of Record online: 20 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01874.x

      • image
      • image
    2. You have free access to this content
      Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma (pages 422–426)

      Graeme P. Currie, John J. Lima, Jim E. Sylvester, Daniel K. C. Lee, Wendy J. R. Cockburn and Brian J Lipworth

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01952.x

  8. Drug Interactions

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects (pages 427–432)

      Mikko Niemi, Janne T. Backman, Mikko Neuvonen and Pertti J. Neuvonen

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01884.x

      • image
      • image
      • image
  9. Drug Metabolism

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver (pages 433–440)

      Z. E. Wilson, A. Rostami-Hodjegan, J. L. Burn, A. Tooley, J Boyle, S. W. Ellis and G. T. Tucker

      Version of Record online: 20 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01881.x

      • image
      • image
  10. Clinical Toxicology

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity (pages 441–450)

      Geoffrey K. Isbister, L. P. Hackett, Andrew H. Dawson, Ian M. Whyte and Anthony J. Smith

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01895.x

      • image
      • image
      • image
  11. Short Reports

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Chest pain during use of bupropion as an aid in smoking cessation (pages 451–452)

      L. De Graaf and W. L. Diemont

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01890.x

    2. You have free access to this content
      Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions (pages 453–457)

      Gilbert O. Kokwaro, Bernhards R. Ogutu, Simon N. Muchohi, Godfrey O. Otieno and Charles R. J. C. Newton

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01951.x

      • image
  12. Book Reviews

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Antidotes: Principles and Clinical Applications (page 458)

      R. E. Ferner

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01856.x

    2. You have free access to this content
      HMG-Co reductase inhibitors (pages 458–459)

      PN Durrington

      Version of Record online: 29 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01867.x

  13. Letters to the Editors

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Reviews
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics and Pharmacodynamics
    8. Pharmacogenetics
    9. Drug Interactions
    10. Drug Metabolism
    11. Clinical Toxicology
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editors
    1. You have free access to this content
      Statins and the risk of idiopathic venous thromboembolism (page 460)

      Joel G. Ray and Muhammad M. Mamdani

      Version of Record online: 4 AUG 2003 | DOI: 10.1046/j.1365-2125.2003.01896.x

    2. You have free access to this content
      Author's response to letter from Ray et al. (pages 461–462)

      Chen-Chang Yang and Susan S. Jick

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01960.x

    3. You have free access to this content
      Erratum (page 463)

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01976.x

    4. You have free access to this content
      Erratum (page 464)

      Version of Record online: 12 SEP 2003 | DOI: 10.1046/j.1365-2125.2003.01982.x

    5. You have free access to this content

SEARCH

SEARCH BY CITATION